Protocol Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study
Introduction Multiple sclerosis (MS) is characterized pathologically by demyelination, axonal loss, and glial scar formation. Clinically, most patients have a relapsing-remitting course of MS (RRMS)